Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature

British Journal of Cancer

Volumn 94, Issue 12, 2006, Pages 1823-1832

  Des Guetz, G ^a   Uzzan, B ^a   Nicolas, P ^a   Cucherat, M ^b   Morere, J F ^a   Benamouzig, R ^a   Breau, J L ^a   Perret, G Y ^a  

^a AVICENNE HOSPITAL   (France)

^b UNIVERSITÉ LYON 1   (France)

Author keywords

Colorectal cancer; Microvessel density; Prognostic factors; Survival; VEGF expression

Indexed keywords

ANTIBODY; BIOLOGICAL MARKER; BLOOD CLOTTING FACTOR 8; VASCULOTROPIN;

ADULT; ANGIOGENESIS; ARTICLE; COLORECTAL CANCER; CONFIDENCE INTERVAL; DATA ANALYSIS; DRUG RESPONSE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RISK ASSESSMENT; STATISTICS; SURVIVAL;

ADENOCARCINOMA; AGED; ANTIGENS, CD31; ANTIGENS, CD34; CAPILLARIES; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FACTOR VIII; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; SURVIVAL ANALYSIS; SURVIVAL RATE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33745102388     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603176     Document Type: Article

References (77)

1. Abdalla SA, Behzad F, Bsharah S, Kumar S, Amini SK, O'Dwyer ST, Haboubi NY (1999) Prognostic relevance of microvessel density in colorectal tumours. Oncol Rep 6: 839-842
2. Altman DG (2001) Systematic reviews in health care: systematic reviews of evaluations of prognostic variables. BMJ 323: 224-228
3. Amaya H, Tanigawa N, Lu C, Matsumura M, Shimomatsuya T, Horiuchi T, Muraoka R (1997) Association of vascular endothelial growth factor expression with tumor angiogenesis, survival and thymidine phosphorylase/platelet-derived endothelial cell growth factor expression in human colorectal cancer. Cancer Lett 119: 227-235
4. Banner BF, Whitehouse R, Baker SP, Swanson RS (1998) Tumor angiogenesis in stage II colorectal carcinoma: association with survival. Am J Clin Pathol 109: 733-737
5. Barozzi C, Ravaioli M, D'Errico A, Grazi GL, Poggioli G, Cavrini G, Mazziotti A, Grigioni WF (2002) Relevance of biologic markers in colorectal carcinoma: a comparative study of a broad panel. Cancer 94: 647-657
6. Bossi P, Viale G, Lee AK, Alfano R, Coggi G, Bosari S (1995) Angiogenesis in colorectal tumors: microvessel quantitation in adenomas and carcinomas with clinicopathological correlations. Cancer Res 55: 5049-5053
7. Cascinu S, Graziano F, Catalano V, Staccioli MP, Rossi MC, Baldelli AM, Barni S, Brenna A, Secondino S, Muretto P, Catalano G (2002) An analysis of p53, BAX and vascular endothelial growth factor expression in node-positive rectal cancer. Relationships with tumour recurrence and event-free survival of patients treated with adjuvant chemoradiation. Br J Cancer 86: 744-749
8. Cascinu S, Graziano F, Valentini M, Catalano V, Giordani P, Staccioli MP, Rossi C, Baldelli AM, Grianti C, Muretto P, Catalano G (2001) Vascular endothelial growth factor expression, S-phase fraction and thymidylate synthase quantitation in node-positive colon cancer: relationships with tumor recurrence and resistance to adjuvant chemotherapy. Ann Oncol 12: 239-244
9. Cascinu S, Staccioli MP, Gasparini G, Giordani P, Catalano V, Ghiselli R, Rossi C, Baldelli AM, Graziano F, Saba V, Muretto P, Catalano G (2000) Expression of vascular endothelial growth factor can predict event-free survival in stage II colon cancer. Clin Cancer Res 6: 2803-2807
10. Chalkley HW (1943) Method for the quantitative morphologic analysis of tissues. J Natl Cancer Inst 4: 47-53
11. Choi HJ, Hyun MS, Jung GJ, Kim SS, Hong SH (1998) Tumor angiogenesis as a prognostic predictor in colorectal carcinoma with special reference to mode of metastasis and recurrence. Oncology 55: 575-581
12. Cianchi F, Palomba A, Messerini L, Boddi V, Asirelli G, Perigli G, Bechi P, Taddei A, Pucciani F, Cortesini C (2002) Tumor angiogenesis in lymph node-negative rectal cancer: correlation with clinicopathological parameters and prognosis. Ann Surg Oncol 9: 20-26
13. Cucherat M, Boissel JP, Leizorovicz A, Haugh MC (1997) EasyMA: a program for the meta-analysis of clinical trials. Comput Methods Programs Biomed 53: 187-190
14. Engel CJ, Bennett ST, Chambers AF, Doig GS, Kerkvliet N, O'Malley FP (1996) Tumor angiogenesis predicts recurrence in invasive colorectal cancer when controlled for Dukes staging. Am J Surg Pathol 20: 1260-1265
15. Fox SH, Whalen GF, Sanders MM, Burleson JA, Jennings K, Kurtzman S, Kreutzer D (1998) Angiogenesis in normal tissue adjacent to colon cancer. J Surg Oncol 69: 230-234
16. Frank RE, Saclarides TJ, Leurgans S, Speziale NJ, Drab EA, Rubin DB (1995) Tumor angiogenesis as a predictor of recurrence and survival in patients with node-negative colon cancer. Ann Surg 222: 695-699
17. Furudoi A, Tanaka S, Haruma K, Kitadai Y, Yoshihara M, Chayama K, Shimamoto F (2002) Clinical significance of vascular endothelial growth factor C expression and angiogenesis at the deepest invasive site of advanced colorectal carcinoma. Oncology 62: 157-166
18. Galindo-Gallego M, Fernandez-Acenero MJ, Sanz-Ortega J, Aljama A, Lopez-Elzaurdia C (2000) Prognostic significance of microvascular counts in rectal carcinoma. Pathol Res Pract 196: 607-612
19. Galindo Gallego M, Fernandez Acenero MJ, Sanz Ortega J, Aljama A (2000) Vascular enumeration as a prognosticator for colorectal carcinoma. Eur J Cancer 36: 55-60
20. Galizia G, Lieto E, Ferraraccio F, Orditura M, De Vita F, Castellano P, Imperatore V, Romano C, Ciardiello F, Agostini B, Pignatelli C (2004) Determination of molecular marker expression can predict clinical outcome in colon carcinomas. Clin Cancer Res 10: 3490-3499
21. Garcea G, Lloyd TD, Gescher A, Dennison AR, Steward WP, Berry DP (2004) Angiogenesis of gastrointestinal tumours and their metastases-a target for intervention? Eur J Cancer 40: 1302-1313
22. Giatromanolaki A, Sivridis E, Minopoulos G, Polychronidis A, Manolas C, Simopoulos C, Koukourakis MI (2002) Differential assessment of vascular survival ability and tumor angiogenic activity in colorectal cancer. Clin Cancer Res 8: 1185-1191
23. Gill S, Loprinzi CL, Sargent DJ, Thome SD, Alberts SR, Haller DG, Benedetti J, Francini G, Shepherd LE, Francois Seitz J, Labianca R, Chen W, Cha SS, Heldebrant MP, Goldberg RM (2004) Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much? J Clin Oncol 22: 1797-1806
24. Harada Y, Ogata Y, Shirouzu K (2001) Expression of vascular endothelial growth factor and its receptor KDR (kinase domain-containing receptor)/Flk-1 (fetal liver kinase-1) as prognostic factors in human colorectal cancer. Int J Clin Oncol 6: 221-228
25. Hayes DF, Isaacs C, Stearns V (2001) Prognostic factors in breast cancer: current and new predictors of metastasis. J Mammary Gland Biol Neoplasia 6: 375-392
26. Hellman S, Rosenberg SA (2001) Cancers of the gastrointestinal tract. In Cancer: principles and practice of oncology Vincent Jr TD (ed) 6th ed, pp 1230-1238. Philadelphia, PA: Lippincott
27. Hermanek P, Sobin LH (1995) Prognostic factors in colorectal cancer. In Prognostic factors in cancer Hermanek P (ed) pp 64-79. Berlin: Springer
28. Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W, Berlin J, Baron A, Griffing S, Holmgren E, Ferrara N, Fyfe G, Rogers B, Ross R, Kabbinavar F (2004) Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350: 2335-2342
29. Ishigami SI, Arii S, Furutani M, Niwano M, Harada T, Mizumoto M, Mori A, Onodera H, Imamura M (1998) Predictive value of vascular endothelial growth factor (VEGF) in metastasis and prognosis of human colorectal cancer. Br J Cancer 78: 1379-1384
30. Ishikawa H, Fujii H, Yamamoto K, Morita T, Hata M, Koyama F, Terauchi S, Sugimori S, Kobayashi T, Enomoto H, Yoshikawa S, Nishikawa T, Nakano H (1999) Tumor angiogenesis predicts recurrence with normal serum carcinoembryonic antigen in advanced rectal carcinoma patients. Surg Today 29: 983-991
31. Jubb AM, Hurwitz HI, Bai W, Holmgren EB, Tobin P, Guerrero AS, Kabbinavar F, Holden SN, Novotny WF, Frantz GD, Hillan KJ, Koeppen H (2006) Impact of vascular endothelial growth factor-A expression, thrombospondin-2 expression, and microvessel density on the treatment effect of bevacizumab in metastatic colorectal cancer. J Clin Oncol 24: 217-227
32. Kaio E, Tanaka S, Kitadai Y, Sumii M, Yoshihara M, Haruma K, Chayama K (2003a) Clinical significance of angiogenic factor expression at the deepest invasive site of advanced colorectal carcinoma. Oncology 64: 61-73
33. Kaio E, Tanaka S, Oka S, Hiyama T, Kitadai Y, Haruma K, Chayama K (2003b) Clinical significance of thrombospondin-1 expression in relation to vascular endothelial growth factor and interleukin-10 expression at the deepest invasive tumor site of advanced colorectal carcinoma. Int J Oncol 23: 901-911
34. Khorana AA, Ryan CK, Cox C, Eberly S, Sahasrabudhe DM (2003) Vascular endothelial growth factor, CD68, and epidermal growth factor receptor expression and survival in patients with Stage II and Stage III colon carcinoma: a role for the host response in prognosis. Cancer 97: 960-968
35. Kondo Y, Arii S, Furutani M, Isigami S, Mori A, Onodera H, Chiba T, Imamura M (2000) Implication of vascular endothelial growth factor and p53 status for angiogenesis in noninvasive colorectal carcinoma. Cancer 88: 1820-1827
36. Lackner C, Jukic Z, Tsybrovskyy O, Jatzko G, Wette V, Hoefler G, Klimpfinger M, Denk H, Zatloukal K (2004) Prognostic relevance of tumour-associated macrophages and von Willebrand factor-positive microvessels in colorectal cancer. Virchows Arch 445: 160-167
37. Lee JC, Chow NH, Wang ST, Huang SM (2000) Prognostic value of vascular endothelial growth factor expression in colorectal cancer patients. Eur J Cancer 36: 748-753
38. Li C, Gardy R, Seon BK, Duff SE, Abdalla S, Renehan A, O'Dwyer ST, Haboubi N, Kumar S (2003) Both high intratumoral microvessel density determined using CD105 antibody and elevated plasma levels of CD105 in colorectal cancer patients correlate with poor prognosis. Br J Cancer 88: 1424-1431
39. Liang JT, Huang KC, Jeng YM, Lee PH, Lai HS, Hsu HC (2004) Microvessel density, cyclo-oxygenase 2 expression, K-ras mutation and p53 overexpression in colonic cancer. Br J Surg 91: 355-361
40. Lindmark G, Gerdin B, Sundberg C, Pahlman L, Bergstrom R, Glimelius B (1996) Prognostic significance of the microvascular count in colorectal cancer. J Clin Oncol 14: 461-466
41. Liu X, Song S, Xu W (1999) Microvessel quantitation and expression of VEGF in colorectal tumors. Zhonghua Zhong Liu Za Zhi 21: 430-432
42. Maeda K, Nishiguchi Y, Yashiro M, Yamada S, Onoda N, Sawada T, Kang SM, Hirakawa K (2000) Expression of vascular endothelial growth factor and thrombospondin-1 in colorectal carcinoma. Int J Mol Med 5: 373-378
43. Mamounas E, Wieand S, Wolmark N, Bear HD, Atkins JN, Song K, Jones J, Rockette H (1999) Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer: results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03, and C-04). J Clin Oncol 17: 1349-1355
44. Mooteri S, Rubin D, Leurgans S, Jakate S, Drab E, Saclarides T (1996) Tumor angiogenesis in primary and metastatic colorectal cancers. Dis Colon Rectum 39: 1073-1080
45. Nanashima A, Ito M, Sekine I, Naito S, Yamaguchi H, Nakagoe T, Ayabe H (1998) Significance of angiogenic factors in liver metastatic tumors originating from colorectal cancers. Dig Dis Sci 43: 2634-2640
46. Nanni O, Volpi A, Frassineti GL, De Paola F, Granato AM, Dubini A, Zoli W, Scarpi E, Turci D, Oliverio G, Gambi A, Amadori D (2002) Role of biological markers in the clinical outcome of colon cancer. Br J Cancer 87: 868-875
47. Onogawa S, Kitadai Y, Tanaka S, Kuwai T, Kimura S, Chayama K (2004) Expression of VEGF-C and VEGF-D at the invasive edge correlates with lymph node metastasis and prognosis of patients with colorectal carcinoma. Cancer Sci 95: 32-39
48. Papamichael D (2001) Prognostic role of angiogenesis in colorectal cancer. Anticancer Res 21: 4349-4353
49. Parmar MK, Torri V, Stewart L (1998) Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 17: 2815-2834
50. Pavlopoulos PM, Konstantinidou AE, Agapitos E, Kavantzas N, Nikolopoulou P, Davaris P (1998) A morphometric study of neovascularization in colorectal carcinoma. Cancer 83: 2067-2075
51. Pietra N, Sarli L, Caruana P, Cabras A, Costi R, Gobbi S, Bordi C, Peracchia A (2000) Is tumour angiogenesis a prognostic factor in patients with colorectal cancer and no involved nodes? Eur J Surg 166: 552-556
52. Poon RT, Fan ST, Wong J (2003) Clinical significance of angiogenesis in gastrointestinal cancers: a target for novel prognostic and therapeutic approaches. Ann Surg 238: 9-28
53. Prall F, Gringmuth U, Nizze H, Barten M (2003) Microvessel densities and microvascular architecture in colorectal carcinomas and their liver metastases: significant correlation of high microvessel densities with better survival. Histopathology 42: 482-491
54. Saad RS, Liu YL, Nathan G, Celebrezze J, Medich D, Silverman JF (2004) Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in colorectal cancer. Mod Pathol 17: 197-203
55. Saclarides TJ, Speziale NJ, Drab E, Szeluga DJ, Rubin DB (1994) Tumor angiogenesis and rectal carcinoma. Dis Colon Rectum 37: 921-926
56. Seto S, Onodera H, Kaido T, Yoshikawa A, Ishigami S, Arii S, Imamura M (2000) Tissue factor expression in human colorectal carcinoma: correlation with hepatic metastasis and impact on prognosis. Cancer 88: 295-301
57. Shan YS, Lee JC, Chow NH, Yang HB, Wang ST (2003) Immunohistochemical microvessel count is not a reliable prognostic predictor in colorectal carcinoma. Hepatogastroenterology 50: 1316-1320
58. Sokmen S, Sarioglu S, Fuzun M, Terzi C, Kupelioglu A, Aslan B (2001) Prognostic significance of angiogenesis in rectal cancer: a morphometric investigation. Anticancer Res 21: 4341-4348
59. Sternfeld T, Foss HD, Kruschewski M, Runkel N (1999) The prognostic significance of tumor vascularization in patients with localized colorectal cancer. Int J Colorectal Dis 14: 272-276
60. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283: 2008-2012
61. Takahashi Y, Tucker SL, Kitadai Y, Koura AN, Bucana CD, Cleary KR, Ellis LM (1997) Vessel counts and expression of vascular endothelial growth factor as prognostic factors in node-negative colon cancer. Arch Surg 132: 541-546
62. Takebayashi Y, Aklyama S, Yamada K, Akiba S, Aikou T (1996) Angiogenesis as an unfavorable prognostic factor in human colorectal carcinoma. Cancer 78: 226-231
63. Tamura M, Oda M, Tsunezuka Y, Matsumoto I, Kawakami K, Watanabe G (2004) Vascular endothelial growth factor expression in metastatic pulmonary tumor from colorectal carcinoma: utility as a prognostic factor. J Thorac Cardiovasc Surg 128: 517-522
64. Tanigawa N, Amaya H, Matsumura M, Lu C, Kitaoka A, Matsuyama K, Muraoka R (1997) Tumor angiogenesis and mode of metastasis in patients with colorectal cancer. Cancer Res 57: 1043-1046
65. Tokunaga T, Oshika Y, Abe Y, Ozeki Y, Sadahiro S, Kijima H, Tsuchida T, Yamazaki H, Ueyama Y, Tamaoki N, Nakamura M (1998) Vascular endothelial growth factor (VEGF) mRNA isoform expression pattern is correlated with liver metastasis and poor prognosis in colon cancer. Br J Cancer 77: 998-1002
66. Tomisaki S, Ohno S, Ichiyoshi Y, Kuwano H, Maehara Y, Sugimachi K (1996) Microvessel quantification and its possible relation with liver metastasis in colorectal cancer. Cancer 77: 1722-1728
67. Uzzan B, Nicolas P, Cucherat M, Perret GY (2004) Microvessel density as a prognostic factor in women with breast cancer: a systematic review of the literature and meta-analysis. Cancer Res 64: 2941-2955
68. van Triest B, Pinedo HM, Blaauwgeers JL, van Diest PJ, Schoenmakers PS, Voorn DA, Smid K, Hoekman K, Hoitsma HF, Peters GJ (2000) Prognostic role of thymidylate synthase, thymidine phosphorylase/platelet-derived endothelial cell growth factor, and proliferation markers in colorectal cancer. Clin Cancer Res 6: 1063-1072
69. Vermeulen PB, Gasparini G, Fox SB, Colpaert C, Marson LP, Gion M, Belien JA, de Waal RM, Van Marck E, Magnani E, Weidner N, Harris AL, Dirix LY (2002) Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours. Eur J Cancer 38: 1564-1579
70. Vermeulen PB, Van den Eynden GG, Huget P, Goovaerts G, Weyler J, Lardon F, Van Marck E, Hubens G, Dirix LY (1999) Prospective study of intratumoral microvessel density, p53 expression and survival in colorectal cancer. Br J Cancer 79: 316-322
71. Vermeulen PB, Verhoeven D, Fierens H, Hubens G, Goovaerts G, Van Marck E, De Bruijn EA, Van Oosterom AT, Dirix LY (1995) Microvessel quantification in primary colorectal carcinoma: an immunohistochemical study. Br J Cancer 71: 340-343
72. Wali RK, Roy HK, Kim YL, Liu Y, Koetsier JL, Kunte DP, Goldberg MJ, Turzhitsky V, Backman V (2005) Increased microvascular blood content is an early event in colon carcinogenesis. Gut 54: 654-660
73. Weidner N, Semple JP, Welch WR, Folkman J (1991) Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 324: 1-8
74. Weitz J, Koch M, Debus J, Hohler T, Galle PR, Buchler MW (2005) Colorectal cancer. Lancet 365: 153-165
75. White JD, Hewett PW, Kosuge D, McCulloch T, Enholm BC, Carmichael J, Murray JC (2002) Vascular endothelial growth factor-D expression is an independent prognostic marker for survival in colorectal carcinoma. Cancer Res 62: 1669-1675
76. Zheng S, Han MY, Xiao ZX, Peng JP, Dong Q (2003) Clinical significance of vascular endothelial growth factor expression and neovascularization in colorectal carcinoma. World J Gastroenterol 9: 1227-1230
77. Zlobec I, Steele R, Compton CC (2005) VEGF as a predictive marker of rectal tumor response to preoperative radiotherapy. Cancer 104: 2517-2521